pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
FMC-220
Solid Tumor
LG Chem Ltd
0
catalysts
Phase 1
FMT-XBI-302
Graft Versus Host Disease (GVHD)
Shenzhen UnknownBio Biotechnology Co Ltd
0
catalysts
Preclinical
FN-2012
Idiopathic Pulmonary Fibrosis
Faknostics LLC
0
catalysts
FOAMING HAND WASH
FOAMING HAND WASH (CHLORHEXIDINE GLUCONATE)
XTTRIUM
← prev
page 96 of 271
next →
131
Pain
89
Neurology
1
0
catalysts
FOCALIN XR
FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE)
Sandoz Inc
0
catalysts
FOLLISTIM AQ
FOLLISTIM AQ (FOLLITROPIN ALFA/BETA)
Organon USA LLC
0
catalysts
Preclinical
FORCEM-23D
Duchenne Muscular Dystrophy
$DYN
Dyne Therapeutics, Inc.
0
catalysts
Phase 1
FORX-428
Metastatic Breast Cancer
FoRx Therapeutics AG
0
catalysts
FORZINITY
FORZINITY (ELAMIPRETIDE HYDROCHLORIDE)
Stealth BioTherapeutics Inc
0
catalysts
FOSAMAX
FOSAMAX (ALENDRONATE SODIUM)
1 INDICATIONS AND USAGE FOSAMAX PLUS D is a combination of a bisphosphonate a…
Farnesyl pyrophosphate synthase
$OGN
Organon & Co.
0
catalysts
FOSAMAX PLUS D
FOSAMAX PLUS D (ALENDRONATE SODIUM)
1 INDICATIONS AND USAGE FOSAMAX PLUS D is a combination of a bisphosphonate a…
Farnesyl pyrophosphate synthase
$OGN
Organon & Co.
0
catalysts
FOSAPREPITANT
FOSAPREPITANT (FOSAPREPITANT)
DR REDDYS
0
catalysts
FOSTER AND THRIVE ALLERGY AND CONGESTION D
FOSTER AND THRIVE ALLERGY AND CONGESTION D (FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE)
L PERRIGO CO
0
catalysts
FOUNDAYO
FOUNDAYO (ORFORGLIPRON CALCIUM)
1 INDICATIONS AND USAGE FOUNDAYO TM is indicated in combination with a reduce…
$LLY
ELI LILLY & Co
0
catalysts
Preclinical
FP-016
Unspecified Neurologic Disorders
Foresee Pharmaceuticals Co Ltd
0
catalysts
Preclinical
FP-017
Unspecified Neurologic Disorders
Foresee Pharmaceuticals Co Ltd
0
catalysts
Preclinical
FP-0210
Formosa Pharmaceuticals Inc
0
catalysts
Phase 2
FP-101
Vasomotor Symptoms of Menopause (Hot Flashes)
Fervent Pharmaceuticals LLC
0
catalysts
Phase 1
FPI-2068
Metastatic Colorectal Cancer
Fusion Pharmaceuticals Inc
0
catalysts
Phase 2
FPI-2265
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Fusion Pharmaceuticals Inc
0
catalysts
Phase 1
FS-120
Advanced Malignancy
invoX Pharma Ltd
0
catalysts
Preclinical
FT-002a-O
Castration-Resistant Prostate Cancer (CRPC)
AecorBio Inc
0
catalysts
Phase 1
FT-522
B-Cell Non-Hodgkin Lymphoma
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 1
FT-576
Refractory Multiple Myeloma
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 1
FT-819
Idiopathic Inflammatory Myopathy (IIM)
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 1
FT-825
Colorectal Cancer
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 1
FT-836
Breast Cancer
$FATE
FATE THERAPEUTICS INC
0
catalysts
Preclinical
FT-839
Hematological Tumor
$FATE
FATE THERAPEUTICS INC
0
catalysts
Preclinical
FT-8XX
Unspecified Cancer
$FATE
FATE THERAPEUTICS INC
0
catalysts
FULPHILA
FULPHILA (PEGFILGRASTIM-JMDB)
MYLAN GMBH
0
catalysts
